{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:46:45Z","timestamp":1774324005485,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","onlinecjc.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cjca.2024.12.032","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T01:56:15Z","timestamp":1736042175000},"page":"178-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Invited Commentary: Four Questions About Atrial Fibrillation in Cardiac Amyloidosis: Why Is This Arrhythmia Different From All Other Arrhythmias?"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3329-2033","authenticated-orcid":false,"given":"Rodney H.","family":"Falk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osnat Itzhaki","family":"Ben Zadok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2024.12.032_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/13506129.2024.2398446","article-title":"International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction","volume":"31","author":"Yun","year":"2024","journal-title":"Amyloid"},{"key":"10.1016\/j.cjca.2024.12.032_bib2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"6","author":"AbouEzzeddine","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2024.12.032_bib3","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/ehf2.13851","article-title":"Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis","volume":"9","author":"Papathanasiou","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cjca.2024.12.032_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cjca.2024.10.010","article-title":"Prevalence of cardiac amyloidosis among elderly patients with recent-onset atrioal fibrillation: the PREVAL-ATTR study","volume":"41","author":"Remior-Perez","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2024.12.032_bib5","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-diagnostic criteria and appropriate utilization","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.12.032_bib6","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.12.032_bib7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacep.2023.11.015","article-title":"Prevalence and treatment of atrial fibrillation and flutter in cardiac amyloidosis","volume":"10","author":"Haslett","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2024.12.032_bib8","unstructured":"Schotten U, Goette A, Verheule S. Translation of pathophysiological mechanisms of atrial fibrosis into new diagnostic and therapeutic approaches [E-pub ahead of print]. Nat Rev Cardiol doi: 10.1038\/s41569-024-01088."},{"key":"10.1016\/j.cjca.2024.12.032_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmg.2021.06.022","article-title":"Clinical importance of left atrial infiltration in cardiac transthyretin amyloidosis","volume":"15","author":"Bandera","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.12.032_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae155","article-title":"Clinical outcomes of catheter ablation for atrial fibrillation, atrial flutter, and atrial tachycardia in wild-type transthyretin amyloid cardiomyopathy: a proposed treatment strategy for catheter ablation in each arrhythmia","volume":"26","author":"Kanazawa","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2024.12.032_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.hrthm.2015.09.016","article-title":"Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy","volume":"13","author":"Barbhaiya","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2024.12.032_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.carpath.2013.12.001","article-title":"Atrial fibrillation from the pathologist's perspective","volume":"23","author":"Corradi","year":"2014","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cjca.2024.12.032_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.31083\/j.rcm2411320","article-title":"Research progress of low-voltage areas associated with atrial fibrillation","volume":"24","author":"Gu","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.cjca.2024.12.032_bib14","doi-asserted-by":"crossref","unstructured":"Kwan E, Ghafoori E, Good W, et\u00a0al. Diffuse functional and structural abnormalities in fibrosis: potential structural basis for sustaining atrial fibrillation [E-pub ahead of print]. Heart Rhythm doi: 10.1016\/j.hrthm.2024.10.060.","DOI":"10.1016\/j.hrthm.2024.10.060"},{"key":"10.1016\/j.cjca.2024.12.032_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jacep.2022.11.005","article-title":"Tafamidis and incidence of atrial fibrillation in transthyretin amyloid cardiomyopathy","volume":"9","author":"Girvin","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2024.12.032_bib16","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jacep.2023.03.013","article-title":"Left atrial strain may predict thrombus formation in patients with transthyretin cardiac amyloidosis","volume":"9","author":"Donnellan","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2024.12.032_bib17","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220985","article-title":"The correlation of left atrial dysfunction and amyloid load in patients with immunoglobulin light-chain cardiac amyloidosis: a 3T cardiac magnetic resonance study","volume":"96","author":"Lu","year":"2023","journal-title":"Br J Radiol"},{"key":"10.1016\/j.cjca.2024.12.032_bib18","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcmg.2023.07.003","article-title":"Left atrial function in cardiac amyloidosis","volume":"16","author":"Nagueh","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.12.032_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/hrt.74.5.541","article-title":"Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation","volume":"74","author":"Dubrey","year":"1995","journal-title":"Br Heart J"},{"key":"10.1016\/j.cjca.2024.12.032_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.15420\/aer.2021.51","article-title":"Atrial fibrosis, ischaemic stroke and atrial fibrillation","volume":"10","author":"Mahnkopf","year":"2021","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.cjca.2024.12.032_bib21","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/ehf2.14349","article-title":"Is excessive ventricular irregularity predictive of rehospitalization in patients with permanent AF and HFpEF?","volume":"10","author":"Chaumont","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cjca.2024.12.032_bib22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0735-1097(97)00254-4","article-title":"Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation","volume":"30","author":"Clark","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.12.032_bib23","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/jce.15669","article-title":"The hemodynamic effect of simulated atrial fibrillation on left ventricular function","volume":"33","author":"Stojadinovic","year":"2022","journal-title":"J\u00a0Cardiovasc Electrophysiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X24013291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X24013291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T23:11:02Z","timestamp":1739229062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X24013291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0828282X24013291"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2024.12.032","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invited Commentary: Four Questions About Atrial Fibrillation in Cardiac Amyloidosis: Why Is This Arrhythmia Different From All Other Arrhythmias?","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2024.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2024.10.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}